BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8087793)

  • 41. Automated claim and payment verification.
    Segal MJ; Morris S; Rubin JM
    J Med Pract Manage; 2002; 17(6):297-301. PubMed ID: 12122814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managed care restrictions: barriers to product use in cancer care.
    Fox LA
    Am J Manag Care; 2013; 19(1 Spec No):SP24-5. PubMed ID: 23461469
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of cost data, provider experience, and clinical guidelines in the transition to managed care.
    Swanson GH
    J Insur Med; 1991; 23(1):70-4. PubMed ID: 10147773
    [No Abstract]   [Full Text] [Related]  

  • 44. Are health-care reimbursement policies a barrier to acute and cancer pain management?
    Joranson DE
    J Pain Symptom Manage; 1994 May; 9(4):244-53. PubMed ID: 8089540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current issues in pharmaceutical reimbursement.
    Fijalka S; Fye D; Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.
    Daroudi R; Mirzania M; Zendehdel K
    Int J Health Policy Manag; 2015 Oct; 5(2):99-105. PubMed ID: 26927395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physician payment 2008 for interventionalists: current state of health care policy.
    Manchikanti L; Giordano J
    Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reimbursement issues in cancer clinical trials.
    McKenna RJ
    Cancer; 1990 May; 65(10 Suppl):2405-6. PubMed ID: 2346567
    [No Abstract]   [Full Text] [Related]  

  • 49. State Policies Influence Medicare Telemedicine Utilization.
    Neufeld JD; Doarn CR; Aly R
    Telemed J E Health; 2016 Jan; 22(1):70-4. PubMed ID: 26218148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.
    Muldoon LD; Pelizzari PM; Lang KA; Vandigo J; Pyenson BS
    Health Aff (Millwood); 2018 May; 37(5):743-750. PubMed ID: 29733731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medicare Advantage's private fee-for-service plans: paying for coordinated care without the coordination.
    Biles B; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2008 Oct; 48():1-12. PubMed ID: 18953765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care organizations (MCOs) and insurance providers: 1998 update and cohort analysis.
    Pelletier KR; Astin JA; Haskell WL
    Am J Health Promot; 1999; 14(2):125-33. PubMed ID: 10724724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer clinical trials. A case for collaboration.
    Purvis JD
    Cancer; 1990 May; 65(10 Suppl):2391-3. PubMed ID: 2334880
    [No Abstract]   [Full Text] [Related]  

  • 55. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The reimbursement factor in pharmaceutical regulation: rebates, cost-effectiveness, and practice guidelines.
    Shulman SR
    Pharmacoeconomics; 1992; 1(Suppl 1):21-7. PubMed ID: 10146927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
    Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
    Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Home Parenteral Nutrition Reimbursement and American Society for Parenteral and Enteral Nutrition Public Policy Efforts.
    Murphy L; Allen P; Bond B; Guenter P
    Nutr Clin Pract; 2018 Jun; 33(3):316-324. PubMed ID: 29603389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consideration of insurance reimbursement for physical activity and exercise programs for patients with diabetes.
    Pahor M
    JAMA; 2011 May; 305(17):1808-9. PubMed ID: 21540427
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.